BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27283773)

  • 1. Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.
    Kishibe M; Baida G; Bhalla P; Lavker RM; Schlosser B; Iinuma S; Yoshida S; Dudley JT; Budunova I
    Oncotarget; 2016 Oct; 7(43):69479-69488. PubMed ID: 27283773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cells in the hair follicle bulge do not contribute to epidermal regeneration after glucocorticoid-induced cutaneous atrophy.
    Chebotaev DV; Yemelyanov AY; Lavker RM; Budunova IV
    J Invest Dermatol; 2007 Dec; 127(12):2749-58. PubMed ID: 17657244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
    Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ
    Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids.
    Baida G; Bhalla P; Kirsanov K; Lesovaya E; Yakubovskaya M; Yuen K; Guo S; Lavker RM; Readhead B; Dudley JT; Budunova I
    EMBO Mol Med; 2015 Jan; 7(1):42-58. PubMed ID: 25504525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
    Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
    EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
    Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
    Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-related peptidase 8-dependent skin wound healing is associated with upregulation of kallikrein-related peptidase 6 and PAR2.
    Kishibe M; Bando Y; Tanaka T; Ishida-Yamamoto A; Iizuka H; Yoshida S
    J Invest Dermatol; 2012 Jun; 132(6):1717-24. PubMed ID: 22358061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells in the hair follicle and interfollicular epidermis of mice following topical application of fluocinolone acetonide.
    Morris RJ
    J Invest Dermatol; 2007 Dec; 127(12):2707-8. PubMed ID: 18007689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proinflammatory role of KLK6 protease in Netherton syndrome.
    Zingkou E; Pampalakis G; Charla E; Nauroy P; Kiritsi D; Sotiropoulou G
    J Dermatol Sci; 2019 Jul; 95(1):28-35. PubMed ID: 31255470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation.
    Bigas J; Sevilla LM; Carceller E; Boix J; Pérez P
    Cell Death Dis; 2018 May; 9(6):588. PubMed ID: 29789551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
    Kowalczyk P; Kinjo T; Kowalczyk M; Walaszek Z; Hanausek M; Slaga TJ
    Eur J Pharmacol; 2009 May; 610(1-3):29-36. PubMed ID: 19306867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
    Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
    J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLK6 protease accelerates skin tumor formation and progression.
    Khoury N; Zingkou E; Pampalakis G; Sofopoulos M; Zoumpourlis V; Sotiropoulou G
    Carcinogenesis; 2018 Dec; 39(12):1529-1536. PubMed ID: 30137206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy.
    Lesovaya E; Agarwal S; Readhead B; Vinokour E; Baida G; Bhalla P; Kirsanov K; Yakubovskaya M; Platanias LC; Dudley JT; Budunova I
    J Invest Dermatol; 2018 Sep; 138(9):1935-1944. PubMed ID: 29596905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
    Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of putative hyalurosome platform in keratinocytes as a mechanism for corticosteroid-induced epidermal atrophy.
    Barnes L; Ino F; Jaunin F; Saurat JH; Kaya G
    J Invest Dermatol; 2013 Apr; 133(4):1017-26. PubMed ID: 23223147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REDD1 (regulated in development and DNA damage 1) modulates the glucocorticoid receptor function in keratinocytes.
    Chudakova DA; Trubetskoy D; Baida G; Bhalla P; Readhead B; Budunova I
    Exp Dermatol; 2023 Oct; 32(10):1725-1733. PubMed ID: 37483165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation.
    Sevilla LM; Latorre V; Sanchis A; Pérez P
    J Invest Dermatol; 2013 Feb; 133(2):361-70. PubMed ID: 22951731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.
    Maubec E; Laouénan C; Deschamps L; Nguyen VT; Scheer-Senyarich I; Wackenheim-Jacobs AC; Steff M; Duhamel S; Tubiana S; Brahimi N; Leclerc-Mercier S; Crickx B; Perret C; Aractingi S; Escoubet B; Duval X; Arnaud P; Jaisser F; Mentré F; Farman N
    J Invest Dermatol; 2015 Jul; 135(7):1781-1789. PubMed ID: 25668238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid.
    Tang XH; Vivero M; Gudas LJ
    Exp Cell Res; 2008 Jan; 314(1):38-51. PubMed ID: 17727842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.